NASDAQ:INM

InMed Pharmaceuticals Inc. Common Shares

Stock

USD

Last Close

0.25

30/04 13:59

Market Cap

1.42M

Beta: 1.06

Volume Today

14.40K

Avg: 631.00K

PE Ratio

−0.16

PFCF: −0.24

Overview Financials Filings timeline people Ownership API Chart Data

locale
United States
market
STOCKS
industry
Biotechnology
website
www.inmedpharma.com
ipo date
May 05, 2014

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn wh...Show More

NASDAQ:INM

InMed Pharmaceuticals Inc. Common Shares

Last Close

0.25

30/04 13:59

Market Cap

1.42M

Beta: 1.06

Volume Today

14.40K

Avg: 631.00K

PE Ratio

−0.16

PFCF: −0.24

locale

market

industry

website

ipo date

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics

Please Sign In To Use The Chat